Cashu | Summary

DJI

-0.18%

SPX

+0.56%

IXIC

+1.22%

FTSE

+0.44%

N225

-0.88%

AXJO

-1.82%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

-0.18%

SPX

+0.56%

IXIC

+1.22%

FTSE

+0.44%

N225

-0.88%

AXJO

-1.82%

HomeWatchlistNewsSignalsPicks

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap

304.15M

Dividend Yield

0.00%

P/E Ratio

-3.47

EPS

-1.34

Revenue

15.00K

Avg. Volume

3.66M

About

What does ALT do?

Altimmune, a clinical-stage biopharmaceutical company in Gaithersburg, Maryland, develops peptide-based therapeutics for obesity and liver diseases, including the lead candidate pemvidutide. The company has completed Phase II trials for both pemvidutide and HepTcell, targeting metabolic dysfunction and hepatitis B.

Sector

💻 Health Care

IPO

CEO

Employees

Headquarters

Maryland, USA

Website

http://altimmune.com